KRTL BioTech

Latest News on private equity markets

Apple, Boeing lead Wall Street higher

Wall Street edged higher on Wednesday, led by gains in Boeing and Apple shares, even as weak earnings from Caterpillar and Texas Instruments raised concerns about the impact of the U.S.-China trade war on global growth.



4 years ago

Nasdaq cancels trades in about 50 securities

Nasdaq Inc said it canceled trades that spanned a two-minute period before the opening bell on Wednesday which affected about 50 securities.



4 years ago

Bitcoin plunges to five-month low vs dollar after Zuckerberg testimony

Bitcoin's price dropped on Wednesday to its lowest level against the dollar since the middle of May after Facebook Chief Executive Officer Mark Zuckerbeg, in testimony before Congress, expressed doubts about whether the company's cryptocurrency project Libra was going to work.



4 years ago

Snap drops as Wall Street puts focus on disappointing revenue outlook

Shares of Snap Inc fell 6% on Wednesday, as Wall Street focused more on a disappointing revenue outlook than regulators no longer investigating the company over whether it misled investors at the time of its 2017 initial public offering.



4 years ago

Metro Bank reports third-quarter loss, deposit outflows as Chairman exits

Britain's troubled Metro Bank reported a loss for the third quarter, said its chairman Vernon Hill has stepped down two months early, and warned it may have to curb its growth plans as it battles to recover from an accounting scandal.



4 years ago

Software stocks were thought to be a can't miss trade this year, but now they are struggling

A slowing economy is forcing companies to spend less on information technology services, pressuring the high-flying software stocks that rely heavily on corporate dollars.

4 years ago

Boeing is 'hopeful' planes will be part of China trade deal as lack of orders forces production cut

Boeing is monitoring the trade war with China, as tariffs push the company to plan production cuts of its 787 Dreamliner.

4 years ago

WeWork's Claure warns layoffs are coming

WeWork's new executive chairman Marcelo Claure wrote in a memo to employees on Wednesday that layoffs were in the works at the U.S. office-space sharing start-up following a $9.5 billion rescue financing deal with SoftBank Group Corp .



4 years ago

Caterpillar cuts profit outlook as China construction sales slump

Industrial bellwether Caterpillar Inc reported a drop in sales in the United States and China in the third quarter, leading it to cut its outlook for the year and adding to evidence that the global economy is firmly on the decline.



4 years ago

Health insurer Anthem signals better-than-feared 2020 earnings, shares rise

Anthem Inc on Wednesday signaled earnings for 2020 could be better than feared, allaying some concerns that rising medical costs are eating into profits and sending shares of the No. 2 health insurer up 4%.



4 years ago

Oil rises on surprise U.S. crude drawdown, prospect of OPEC action

Oil rose nearly 2% on Wednesday after government data showed a surprise draw in U.S. crude stocks and as the prospect of deeper output cuts by OPEC and its allies offered support.



4 years ago

Walmart offers holiday deals early to avoid shorter holiday season

Walmart Inc will offer online holiday deals a few days earlier this year in order to minimize the impact from a shorter selling period between Thanksgiving and Christmas, the retailer said on Wednesday.



4 years ago

Boeing sees 737 MAX U.S. approval before year-end, shares rise

Boeing Co said on Wednesday it still expects U.S. regulatory approval for its grounded 737 MAX in the fourth quarter, sending its shares higher despite a slump in quarterly profit.



4 years ago

Apple, Boeing keep Wall Street afloat, weak earnings stoke growth fears

Wall Street was supported by gains in Apple and Boeing shares on Wednesday, though weak earnings from Caterpillar and Texas Instruments raised concerns of an impact from the U.S.-China trade war on global growth.



4 years ago

Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar

Teva Pharmaceutical Industries Ltd's proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.



4 years ago